{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:30:29Z","timestamp":1787985029195,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Benign prostatic hyperplasia (BPH) is a known cause of bladder outlet obstruction (BOO) in aging men. Patients present with lower urinary tract symptoms (LUTS), elevated postvoid residual urine (PVR), and reduced peak flow rate of urine. Although urodynamic study is the gold standard for diagnosing and quantifying BOO, it is invasive and as such urologists in their routine practice frequently rely on less invasive methods like PVR estimation to objectively assess BOO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To study the prevalence and distribution of PVR in a hospital-based population of men with symptomatic BPH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Patients aged 40 years and above were enrolled for the study. History was taken from each of the 170 participants recruited, and physical examination was done including digital rectal examination. Every one of them completed the International Prostate Symptom Score (IPSS) questionnaire and also had ultrasonography assessment of PVR. Relevant laboratory investigations (PSA, renal function test, full blood count, urinalysis, and urine culture) and uroflowmetry to determine the peak flow rate of urine (Qmax) were done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 170 subjects who met the inclusion criteria were enrolled for this study. The mean age of the subjects was 63.70 \u00b1 9.92 years with a range of 42\u201388 years. The subjects had a mean PSA of 2.68 \u00b1 0.91 ng\/ml and a mean prostate volume of 70.8 \u00b1 39.5 ml. The prevalence of significant PVR was 57.06%. The distribution of PVR was skewed with values ranging from 4.0 ml to 382.9 ml, a median value of 60.5 ml (interquartile range, IQR, =25.0\u2013100.76), and a mean value of 77.70 \u00b1 69.30 ml. An IPSS range of 8 to 23 with a mean value of 13.64 \u00b1 4.14 and a median value of 13 (interquartile range = 10.0-16.0) was observed. The Qmax range was from 5 ml\/s to 50 ml\/s with a mean value of 20.25 \u00b1 9.70 ml\/s, and a median value of 18.0 ml\/s (interquartile range = 14.0\u201324.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study showed that the prevalence of significant PVR volume among men with symptomatic BPH in our environment is high. There was also a high variation in the distribution of PVR among the subjects. Therefore, it is essential to create more public awareness especially among men in their fourth decade of life and above to visit a urologist whenever they have BPH symptoms so as to avoid impairment in quality of life and renal function associated with neglected significant PVR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_339_23","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T23:00:50Z","timestamp":1703890850000},"page":"1839-1843","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and Distribution of Postvoid Residual Urine Volume in a Hospital-Based Sample of Men with Symptomatic Benign Prostatic Hyperplasia"],"prefix":"10.4103","volume":"26","author":[{"given":"SK","family":"Anyimba","sequence":"first","affiliation":[{"name":"Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OC","family":"Amu","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"II","family":"Nnabugwu","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AD","family":"Okoh","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CD","family":"Nwachukwu","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"Iwenofu","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"R1-20260429","first-page":"34","article-title":"Role of uroflowmetry in lower urinary tract symptoms evaluation due to benign prostatic hyperplasia. Annals of king Edward Medical University","volume":"16","author":"Malik","year":"2010","journal-title":"Annals of KEMU"},{"key":"R2-20260429","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000112611","article-title":"Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?","volume":"80","author":"G\u00fcler","year":"2008","journal-title":"Urol Int"},{"key":"R4-20260429","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follows-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"R5-20260429","first-page":"234","article-title":"Sonographic assessment of postvoid residual urine volumes in patients with benign prostatic hyperplasia","volume":"96","author":"Adewumi","year":"2004","journal-title":"J Natl med Assoc"},{"key":"R6-20260429","first-page":"365","article-title":"Clinical utility of a portable ultrasound scanner in the measurement of residual urine","volume":"37","author":"Ding","year":"1996","journal-title":"Singapore Med J"},{"key":"R7-20260429","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005392-199707000-00016","article-title":"Accuracy of residual urine measurement in men: Comparison between real time ultrasonography and catherization","volume":"158","author":"Simforoosh","year":"1997","journal-title":"J Urol"},{"key":"R8-20260429","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0022-5347(17)32314-5","article-title":"The accuracy of portable ultrasound scanning in the measurement of residual urine volume","volume":"152","author":"Coombes","year":"1994","journal-title":"J Urol"},{"key":"R9-20260429","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02765813","article-title":"Portable ultrasound determination of urinary residual volume","volume":"8","author":"Bent","year":"1997","journal-title":"Int Urogynecol J"},{"key":"R10-20260429","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1464-410X.1985.tb06299.x","article-title":"Ultrasound assessment of residuals urine: A qualitative method","volume":"57","author":"Beacock","year":"1985","journal-title":"Br J Urol"},{"key":"R11-20260429","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF02552157","article-title":"Measurements of residual urine volume using a portable ultrasound instrument","volume":"28","author":"Fuse","year":"1996","journal-title":"Int Urol Nephrol"},{"key":"R13-20260429","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/1119-3077.113446","article-title":"The value of International prostate symptom scoring system in the management of BPH in JOS, Nigeria","volume":"16","author":"Amu","year":"2013","journal-title":"Niger J Clin Pract"},{"key":"R14-20260429","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.afju.2016.02.004","article-title":"Prevalence of clinical benign prostatic hyperplasia amongst community-dwelling men in a South-West Nigerian rural setting: A cross-sectional study","volume":"23","author":"Ojewola","year":"2017","journal-title":"Afr J Urol"},{"key":"R15-20260429","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4103\/njcp.njcp_67_20","article-title":"Anterior bladder wall thickness, post-void urine residue and bladder emptying efficiency as indicators of dysfunction in Nigerian men with benign prostatic hyperplasia","volume":"23","author":"Eze","year":"2020","journal-title":"Niger J Clin Pract"},{"key":"R16-20260429","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3126\/nmcj.v21i2.25110","article-title":"Correlation between symptom severity and objective parameters in elderly men with lower urinary tract symptoms","volume":"21","author":"Bhomi","year":"2019","journal-title":"Nepal Med Coll J"},{"key":"R17-20260429","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-020-00102-0","article-title":"Correlation of intravesical prostatic protrusion with severity of lower urinary symptoms among patients with benign prostatic hyperplasia","volume":"27","author":"Hamza","year":"2021","journal-title":"Afr J Urol"},{"key":"R18-20260429","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3126\/jucms.v3i1.13248","article-title":"Clinical significance of intravesical prostatic protrusion in patients with benign prostatic hyperplasia","volume":"3","author":"Sigdel","year":"2015","journal-title":"J Univ Coll Med Sci"},{"key":"R19-20260429","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/pcan.2011.43","article-title":"Prevalence of BPH and lower urinary tract symptoms in West Africans","volume":"15","author":"Chokkalingam","year":"2012","journal-title":"Prostate cancer prostatic Dis"},{"key":"R20-20260429","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.afju.2013.03.003","article-title":"Detrusor wall thickness compared to other non-invasive methods in diagnosing men with bladder outlet obstruction: A prospective controlled study","volume":"19","author":"Elsaied","year":"2013","journal-title":"Afr J Urol"},{"key":"R21-20260429","first-page":"454","article-title":"Uroflowmetry evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia an institutional study","volume":"12","author":"Chikkaraddi","year":"2014","journal-title":"Int J Recent Trends Sci Technol"},{"key":"R22-20260429","doi-asserted-by":"crossref","first-page":"86","DOI":"10.9790\/0853-1601058691","article-title":"Correlation of uroflowmetry with lower urinary tract symptoms in patients with symptomatic benign prostatic hyperplasia at eastern part of Nepal: A prospective study","volume":"16","author":"Thapa","year":"2017","journal-title":"IOSR JDMS"},{"key":"R23-20260429","first-page":"1","article-title":"Correlation between the size of the prostate, post void residual volume, PSA level and IPSS in Men with LUTS in three major Urology centres in Khartoum","volume":"9","author":"Hamid","year":"2020","journal-title":"Int J Surg Res"},{"key":"R24-20260429","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1464-410X.2006.06110.x","article-title":"Alfuzocin 10mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: Results of a 2- year placebo-controlled study","volume":"97","author":"Roehrborn","year":"2006","journal-title":"BJU Int"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_339_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:03:13Z","timestamp":1786647793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_339_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_339_23","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2023-05-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}